Patents by Inventor Argeris N. Karabelas

Argeris N. Karabelas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
    Publication number: 20220274951
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Application
    Filed: May 16, 2022
    Publication date: September 1, 2022
    Inventors: Remy Henri LUTHRINGER, Lorenzo PELLEGRINI, Argeris N. KARABELAS
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20210106573
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: June 29, 2020
    Publication date: April 15, 2021
    Inventors: Remy Henri LUTHRINGER, Lorenzo PELLEGRINI, Argeris N. KARABELAS
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
    Publication number: 20180155318
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Application
    Filed: July 21, 2017
    Publication date: June 7, 2018
    Inventors: Remy Henri LUTHRINGER, Lorenzo PELLEGRINI, Argeris N. KARABELAS
  • Methods of use of cyclic amide derivatives to treat schizophrenia
    Patent number: 9732059
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: August 15, 2017
    Assignee: Minerva Neurosciences, Inc.
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20160354357
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: May 24, 2016
    Publication date: December 8, 2016
    Inventors: REMY HENRI LUTHRINGER, LORENZO PELLEGRINI, ARGERIS N. KARABELAS
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SCHIZOPHRENIA
    Publication number: 20130274289
    Abstract: Disclosed herein are compositions and methods for treating schizophrenia and symptoms of schizophrenia, including negative symptoms of schizophrenia.
    Type: Application
    Filed: July 20, 2011
    Publication date: October 17, 2013
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20130274290
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor- mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: July 20, 2011
    Publication date: October 17, 2013
    Applicant: CYRENAIC PHARMACEUTICALS, INC.
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas